Sun Pharma to acquire 100% stake in Antibe

16 Jan 2025 Evaluate

TARO Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries (together with its subsidiaries and/or affiliates referred to as Sun Pharma), has entered into an agreement with Antibe Therapeutics Inc., Canada, pursuant to which Sun Pharma has agreed to acquire 100% stake in Antibe Therapeutics Inc. 

Antibe is currently under court-observed liquidation proceedings and is being managed by a court-appointed receiver. Sun Pharma has entered into a definitive agreement with the receiver to acquire 100% shares in Antibe via a reverse Vesting Order, based on which certain excluded assets and liabilities are transferred to a residual company from Antibe prior to closing.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Sun Pharma Inds. Share Price

1639.60 -3.45 (-0.21%)
24-Feb-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.60
Dr. Reddys Lab 1164.75
Cipla 1476.60
Lupin 1902.45
Zydus Lifesciences 890.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on